""
Skip to content

Molecular Genetics Thalassemia lab of The Cyprus Institute of Neurology and Genetics transforms testing with NGS

In this case study, Dr. Papasavva describes her laboratory’s journey from traditional thalassemia testing to state-of-the-art NGS technology and what a difference this has made in their daily work.

  • Instead of running on average three tests per
    patient, they now only run one and get a
    comprehensive analysis
  • The workflow is fast and simple; with just one
    tube we can test most of the thalassemias
    almost 100%
  • They can save on average 4 weeks for a patient
    waiting for their diagnosis

Get access to the case study by filling out the form below

Infographic

Devyser RHD
Single-exon: High performance without complexity

This infographic details a modern approach to targeted, ethical, and efficient RhD management.

Devyser RHD is a unique non-invasive test solution that determines fetal RHD status from maternal plasma from week 10 of pregnancy. The single-exon kit delivers a turnaround time of less than five hours and a hands-on time of less than 60 minutes. Devyser RHD has a high clinical relevance that is proven from routine usage over the course of years.